Innovating medicines
for breast cancer and beyond.
Innovating medicines
for breast cancer and beyond.
Innovating medicines
for breast cancer and beyond.
Pursuing better treatments to help patients feel better, longer.
Bring your passion, join our team and make your mark.
Olema's latest news and recent events.
-
June 3rd, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
May 28th, 2025 Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
-
May 21st, 2025 Olema Oncology to Participate in Upcoming Investor Conferences
-
May 13th, 2025 Olema Oncology Reports First Quarter 2025 Financial and Operating Results
-
May 9th, 2025 Olema Oncology to Participate in Upcoming Investor Conferences
-
May 2nd, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
June 3rd, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
May 28th, 2025 Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
-
May 21st, 2025 Olema Oncology to Participate in Upcoming Investor Conferences
-
May 13th, 2025 Olema Oncology Reports First Quarter 2025 Financial and Operating Results
-
May 9th, 2025 Olema Oncology to Participate in Upcoming Investor Conferences
-
May 2nd, 2025 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Item 1 of 6